Literature DB >> 33978576

Cardiac and Pulmonary Vascular Risk Stratification in Liver Transplantation.

Blessing Aghaulor1, Lisa B VanWagner2.   

Abstract

Cardiovascular disease complications are the leading cause of early (short-term) mortality among liver transplant recipients. The increasingly older candidate pool has multiple comorbidities necessitating cardiac and pulmonary vascular disease risk stratification of patients for optimal allocation of scarce donor livers. Arrhythmias, heart failure, stroke, and coronary artery disease are common pretransplant cardiovascular comorbidities and contribute to cardiovascular complications after liver transplant. Valvular heart disease and portopulmonary hypertension present intraoperative challenges during liver transplant surgery. The Cardiovascular Risk in Orthotopic Liver Transplantation score estimates the risk of cardiovascular complications in liver transplant candidates within the first year after transplant.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular; Early complications; Liver; Risk factors; Stratification; Transplant

Mesh:

Year:  2020        PMID: 33978576      PMCID: PMC8116621          DOI: 10.1016/j.cld.2020.08.008

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  105 in total

1.  Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database.

Authors:  Mark S Roberts; Derek C Angus; Cindy L Bryce; Zdenek Valenta; Lisa Weissfeld
Journal:  Liver Transpl       Date:  2004-07       Impact factor: 5.799

2.  Successful liver transplantation following medical management of portopulmonary hypertension: a single-center series.

Authors:  N Sussman; V Kaza; N Barshes; R Stribling; J Goss; C O'Mahony; E Zhang; J Vierling; A Frost
Journal:  Am J Transplant       Date:  2006-06-22       Impact factor: 8.086

Review 3.  Cardiovascular risk assessment of the liver transplant candidate.

Authors:  Zankhana Raval; Matthew E Harinstein; Anton I Skaro; Ata Erdogan; Andre M DeWolf; Sanjiv J Shah; Oren K Fix; Nina Kay; Michael I Abecassis; Mihai Gheorghiade; James D Flaherty
Journal:  J Am Coll Cardiol       Date:  2011-07-12       Impact factor: 24.094

4.  Prognostic value of coronary CT angiography and calcium score for major adverse cardiac events in outpatients.

Authors:  Zhi-hui Hou; Bin Lu; Yang Gao; Shi-liang Jiang; Yang Wang; Wei Li; Matthew J Budoff
Journal:  JACC Cardiovasc Imaging       Date:  2012-10

5.  OPTN/SRTR 2017 Annual Data Report: Liver.

Authors:  W R Kim; J R Lake; J M Smith; D P Schladt; M A Skeans; S M Noreen; A M Robinson; E Miller; J J Snyder; A K Israni; B L Kasiske
Journal:  Am J Transplant       Date:  2019-02       Impact factor: 8.086

Review 6.  Cirrhotic Cardiomyopathy After Transplantation: Neither the Transient Nor Innocent Bystander.

Authors:  Manhal Izzy; Jae Oh; Kymberly D Watt
Journal:  Hepatology       Date:  2018-10-13       Impact factor: 17.425

7.  Diabetes mellitus, and not obesity, is associated with lower survival following liver transplantation.

Authors:  Robert J Wong; Ramsey Cheung; Ryan B Perumpail; Edward W Holt; Aijaz Ahmed
Journal:  Dig Dis Sci       Date:  2015-01-18       Impact factor: 3.199

8.  Diabetes, hypertension and hyperlipidemia: prevalence over time and impact on long-term survival after liver transplantation.

Authors:  J Parekh; D A Corley; S Feng
Journal:  Am J Transplant       Date:  2012-04-30       Impact factor: 8.086

9.  Cardiovascular complications following liver transplantation.

Authors:  G W Dec; N Kondo; M L Farrell; J Dienstag; A B Cosimi; M J Semigran
Journal:  Clin Transplant       Date:  1995-12       Impact factor: 2.863

10.  Effects of cardiac valve dysfunction on perioperative management of liver transplantation.

Authors:  I Alper; S Ulukaya; F Demir; M Kilic
Journal:  Transplant Proc       Date:  2009-06       Impact factor: 1.066

View more
  3 in total

Review 1.  Consensus Statement on Hemostatic Management, Anticoagulation, and Antiplatelet Therapy in Liver Transplantation.

Authors:  Eva Montalvá; Manuel Rodríguez-Perálvarez; Annabel Blasi; Santiago Bonanad; Olga Gavín; Loreto Hierro; Laura Lladó; Elba Llop; Juan Carlos Pozo-Laderas; Jordi Colmenero
Journal:  Transplantation       Date:  2022-01-04       Impact factor: 5.385

2.  The Role of Arterial Stiffness in the Estimation of Cardiovascular Risk in Liver Transplant Recipients.

Authors:  Lydia Sastre; Raquel García; Julián-Gonzalo Gándara; Patricia Fernández-Llama; Antonio J Amor; Cristina Sierra; Laia Escudé; Pablo Ruiz; Jordi Colmenero; Emilio Ortega; Miquel Navasa; Gonzalo Crespo
Journal:  Transplant Direct       Date:  2021-12-23

Review 3.  Cardiac risk stratification of the liver transplant candidate: A comprehensive review.

Authors:  Sanjana Nagraj; Spyros Peppas; Maria Gabriela Rubianes Guerrero; Damianos G Kokkinidis; Felipe I Contreras-Yametti; Sandhya Murthy; Ulrich P Jorde
Journal:  World J Transplant       Date:  2022-07-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.